Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients
Recruiting
N/A
Interventional Study
Coagulopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 3 Months – 18
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 125 (estimated)
- Sponsor
- Indiana University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to learn about the performance of the TEG6s in normal pediatric patients. The main questions it aims to answer are: What are the normal TEG 6S lab results in normal pediatric patients and how do they compare to existing published reference ranges. Participants and their guardians will be asked to submit a small amount of blood at the beginning of an elective…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
-Patients less than 18 years of age undergoing elective pediatric surgical care in the operating room at Riley Hospital for Children
Exclusion Criteria:
* Known disorder of coagulation pathway(s)
* Administration of medications that may alter the coagulation cascade
* Patients…
Contacts